NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 25 min ago

Notice of Availability of Administrative Supplements to NIBIB C3i Participants for Advancing Innovation

Thu, 2019-05-09 13:27
Notice NOT-EB-19-013 from the NIH Guide for Grants and Contracts

Notice of Additional Application Requirements for PA-18-823

Thu, 2019-05-09 12:54
Notice NOT-AG-19-022 from the NIH Guide for Grants and Contracts

Notice to Extend the Expiration Date of PAR-16-413: NIAID Investigator Initiated Program Project Applications (P01)

Thu, 2019-05-09 12:48
Notice NOT-AI-19-058 from the NIH Guide for Grants and Contracts

Summer Research Training in Aging for Medical Students (T35 Clinical Trial Not Allowed)

Thu, 2019-05-09 12:37
Funding Opportunity RFA-AG-20-008 from the NIH Guide for Grants and Contracts. The primary goal of this Institutional Research Training Grant is to provide a short-term training for medical students to obtain necessary aging research experiences and technical expertise and skills early during their education to encourages them to pursue career in research.

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50)

Wed, 2019-05-08 12:54
Funding Opportunity RFA-NS-19-031 from the NIH Guide for Grants and Contracts. Reissue of RFA-AR-18-001: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational and clinical research and provide important resources that can be used by the national muscular dystrophy research community. A goal of this Centers program is to support important and innovative research in the muscular dystrophies that is best pursued through this interdisciplinary and collaborative center environment, and projects that may not be as effective if supported by "stand-alone" research project grants. The Centers also provide outstanding environments for the training of new scientists electing to pursue careers conducting research in high priority areas of muscular dystrophy. Finally, Center investigators are expected to engage the patient and advocacy communities in conversations to increase awareness of research, encourage patient participation in research and incorporate the perspectives of these communities in the conduct of patient-centered research.

Pediatric Critical Care Conferences Initiative (R13 Clinical Trial Not Allowed)

Wed, 2019-05-08 11:51
Funding Opportunity RFA-HD-20-012 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for multidisciplinary national conferences that will inform care and facilitate research for major issues in pediatric critical care medicine. Given the nascent stage of development, the small diverse patient populations, and the rapid expansion of the field, conducting research and establishing best practices in pediatric critical care is challenging. National conferences that convene experts from across the country hold the potential to establish the frameworks necessary to overcome these obstacles. It is anticipated that such conferences will foster collaboration among different clinical disciplines, geographically and culturally diverse institutions and medical centers, professional organizations and NIH Institutes. Specifically, it is hoped that these conferences will drive the development and acceptance of uniform definitions, facilitate the determination of common data elements, identify key knowledge gaps to advance research, and/or foster discussions on how research findings can be used to best inform guidelines for patient care .

Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)

Wed, 2019-05-08 10:17
Funding Opportunity PAR-19-277 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications for cancer epidemiologic research. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as improving data collection methods, developing and validating methods of exposures and biological effects, such as epigenetics and metabolomics, and their application in population-based research, functional assessment of genetic variants, and assessing recruitment methods for understudied populations.

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Wed, 2019-05-08 10:05
Funding Opportunity PAR-19-274 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Wed, 2019-05-08 10:04
Funding Opportunity PAR-19-275 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Wed, 2019-05-08 10:04
Funding Opportunity PAR-19-276 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

Wed, 2019-05-08 02:12
Funding Opportunity PAR-19-278 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes. It is expected that any genetic resources generated will be made broadly available to the scientific community to enable investigation of the relevant neurobiological mechanisms involved and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.

Pages